Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0037090 (
Respiratory symptoms
)
467
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hermansky-Pudlak syndrome
(
HPS
) is an autosomal recessive disorder characterized by oculocutaneous albinism, bleeding tendency, and lysosomal accumulation of ceroid-like material, with occasional development of interstitial pneumonia (IP). Nine genetically distinct subtypes of
HPS
are known in humans; IP develops primarily in types 1 and 4. Most reported cases of
HPS
with IP are type 1, and there are no published reports of type 4 in Japanese individuals. A 58-year-old man with congenital oculocutaneous albinism and progressive dyspnea for 1 month was admitted to our hospital. We administered high-dose corticosteroids on the basis of a diagnosis of acute exacerbation of interstitial pneumonia.
Respiratory symptoms
and the findings of high-resolution computed tomography (CT) showed improvement. He was diagnosed with
HPS
type 4 with interstitial pneumonia on the basis of gene analysis. He has been receiving pirfenidone for 1 year and his condition is stable. This is the first report on the use of pirfenidone for
HPS
with IP caused by a novel mutation in the HPS4 gene. We conclude that
HPS
should be suspected in patients with albinism and interstitial pneumonia. High-dose corticosteroid treatment may be useful in cases of acute exacerbation of interstitial pneumonia due to
HPS
-4, and pirfenidone may be useful and well tolerated in patients with
HPS
-4.
...
PMID:Hermansky-Pudlak syndrome type 4 with interstitial pneumonia. 2602 28